Crossref journal-article
Ovid Technologies (Wolters Kluwer Health)
Neurology (276)
Bibliography

Vermersch, P., Sergeant, N., Ruchoux, M. M., Hofmann-Radvanyi, H., Wattez, A., Petit, H., Dewailly, Ph., & Delacourte, A. (1996). Specific tau variants in the brains of patients with myotonic dystrophy. Neurology, 47(3), 711–717.

Authors 8
  1. P. Vermersch (first)
  2. N. Sergeant (additional)
  3. M. M. Ruchoux (additional)
  4. H. Hofmann-Radvanyi (additional)
  5. A. Wattez (additional)
  6. H. Petit (additional)
  7. Ph. Dewailly (additional)
  8. A. Delacourte (additional)
References 51 Referenced 114
  1. Harper PS. Myotonic dystrophy. 2nd ed. London: WB Saunders 1989.
  2. 10.1038/355005a0
  3. Fu YH, Pizzuti RG, Fenwick J, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-1258. / Science (1992)
  4. Jansen G, Mahadevan M, Amemiya C, et al. Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nat Genet 1992;1:261-266. / Nat Genet (1992)
  5. 10.1038/355005a0
  6. 10.1007/BF02266831
  7. 10.1136/jnnp.46.1.9
  8. Chang L, Anderson T, Migneco A, et al. Cerebral abnormalities in myotonic dystrophy: cerebral blood flow, magnetic resonance imaging, and neuropsychological tests. Arch Neurol 1993;50:917-923. / Arch Neurol (1993)
  9. Rosman NP, Kakulas BA. Mental deficiency associated with muscular dystrophy: a neuropathological study. Brain 1966;89:769-788. / Brain (1966)
  10. Wisniewski HM, Berry K, Spiro AJ. Ultrastructure of thalamic neuronal inclusions in myotonic dystrophy. J Neurol Sci 1975;24:321-329. / J Neurol Sci (1975)
  11. Ono S, Inoue K, Mannen T, Kanda F, Jinnai K, Takahashi K. Neuropathological changes of the brain in myotonic dystrophy: some new observations. J Neurol Sci 1987;81:301-320. / J Neurol Sci (1987)
  12. Sarai K, Ishino H, Yoshioka T, Ogura C, Gomyodo M. An autopsy case of myotonic dystrophica. Rinsho Shinkeigaku 1969;9:1-7. / Rinsho Shinkeigaku (1969)
  13. Kuroda S, Ihara Y, Namba R. Neurofibrillary changes in the brains of two siblings with myotonic dystrophy. Neuropathology (Tokyo) 1988;9:43-48. / Neuropathology (Tokyo) (1988)
  14. Mitake S, Inagaki T, Niimi T, Shirai T, Yamamoto M. Development of Alzheimer neurofibrillary changes in two autopsy cases of myotonic dystrophy. Rinsho Shinkeigaku 1989;29:488-492. / Rinsho Shinkeigaku (1989)
  15. 10.1007/BF00310916
  16. 10.1073/pnas.83.1.4
  17. 10.1007/BF00294214
  18. Vermersch P, Robitaille Y, Bernier L, Wattez A, Gauvreau D, Delacourte A. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol (Berl) 1994;87:572-577. / Acta Neuropathol (Berl) (1994)
  19. 10.1097/00005072-199601000-00001
  20. Matsuo EK, Shin RW, Billingsley ML, et al. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994;13:989-1002. / Neuron (1994)
  21. Sergeant N, Bussiere T, Vermersch P, Lejeune JP, Delacourte A. Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins. Neuroreport 1995;6:2217-2220. / Neuroreport (1995)
  22. Reig S, Buee-Scherrer V, Defossez A, Delacourte A, Beauvillain JC, Mazzuca M. Immunogold labeling of paired helical filaments and amyloid filaments by specific monoclonal and polyclonal antibodies. Acta Neuropathol (Berl) 1995;146:924-932. / Acta Neuropathol (Berl) (1995)
  23. Buee-Scherrer V, Condamines O, Mourton-Gilles C, Jakes R, Goedert M, Pau B, Delacourte A. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Brain Res Mol Brain Res 1996;39:79-88. / Brain Res Mol Brain Res (1996)
  24. Brodmann K. Vergleichende Lokalisationslehre der Grosshirnrinde in ihren Prinzipien daigestellt auf Grund des Zellenbaues. Leipzig: JA Barth 1909.
  25. Nieuwenhuys R Voogd J Van Huijzen C. The human central nervous system: a synopsis and atlas. 3rd ed rev. New York: Springer-Verlag 1988. (10.1007/978-3-662-10343-2)
  26. Laemmli UK. Cleavage of structural proteins during head assembly of bacteriophage T4. Nature 1970;227:680-685. / Nature (1970)
  27. 10.1016/S0021-9258(19)41971-6
  28. Szendrei GI, Lee VMY, Otvos J Jr. Recognition of the minimal epitope of monoclonal antibody tau-1 depends upon the presence of a phosphate group but not its location. J Neurosci Res 1993;34:243-249. / J Neurosci Res (1993)
  29. Vermersch P, Frigard B, Delacourte A. Mapping of neurofibrillary degeneration in Alzheimer's disease: evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathol (Berl) 1992;85:48-54. / Acta Neuropathol (Berl) (1992)
  30. 10.1016/0278-5846(94)00100-V
  31. Braak H, Braak E, Grundke-Iqbal I, Iqbal K. Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 1986;65:351-355. / Neurosci Lett (1986)
  32. Lee VMY, Balin BJ, Otvos L, Trojanowski JQ. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 1991;251:675-678. / Science (1991)
  33. Hanger DP, Brion JP, Gallo JM, Cairns NJ, Luthert PJ, Anderton BH. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated. Biochem J 1991;275:99-104. / Biochem J (1991)
  34. 10.1001/archneur.1992.00530250013001
  35. Delacourte A. Pathological tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration. Biomed Pharmacother 1994;48:287-295. / Biomed Pharmacother (1994)
  36. Drewes G, Lichtenberg-Kraag B, Doring F, et al. Mitogen activated protein (MAP) kinase transform tau protein into an Alzheimer state. EMBO J 1992;11:2131-2138. / EMBO J (1992)
  37. Mandelkow EM, Drewes G, Biernat J, et al. Glycogen synthase kinase 3 and the Alzheimer's disease-like state of microtubule-associated protein tau. FEBS Lett 1992;314:315-321. / FEBS Lett (1992)
  38. Paudel HK, Lew J, Zenobia A, Wang JH. Brain prolinedirected protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J Biol Chem 1993;268:23512-23518. / J Biol Chem (1993)
  39. Ledesma MD, Correas L, Avila J, Diaz-Nido J. Implication of brain cdc2 and MAP kinases in the phosphorylation of tau protein in Alzheimer's disease. FEBS Lett 1992;308:218-224. / FEBS Lett (1992)
  40. Vulliet R, Halloran SM, Braun RK, Smith AJ, Lee G. Proline-directed phosphorylation of human tau protein. J Biol Chem 1992;267:22570-22574. / J Biol Chem (1992)
  41. 10.1016/0092-8674(92)90200-V
  42. Sabourin LA, Mahadevan MS, Narang M, Lee DSC, Surh LC, Korneluk RG. Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. Nat Genet 1993;4:233-238. / Nat Genet (1993)
  43. Fu YH, Friedman DL, Richards S, et al. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 1993;260:235-238. / Science (1993)
  44. Wang J, Pegoraro E, Menegazzo E, et al. Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum Mol Genet 1995;4:599-606. / Hum Mol Genet (1995)
  45. Yamamoto KK, Gonzalez GA, Biggs WH, Montminy MR. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 1988;334:494-498. / Nature (1988)
  46. Foullkes NS, Borrelli E, Sassone-Corsi P. CREM gene: use of alternative DNA binding domains generates multiple antagonists of cAMP-induced transcription. Cell 1991;64:739-749. / Cell (1991)
  47. Shaw DJ, McCurrach M, Rundle SA, et al. Genomic organization and transcriptional units at the myotonic dystrophy locus. Genomics 1993;18:673-679. / Genomics (1993)
  48. Jansen G, Mahadevan M, Amemiya C, et al. Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nat Genet 1992;1:261-266. / Nat Genet (1992)
  49. Martin GM. Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth Defects 1978;14:5-39. / Birth Defects (1978)
  50. 10.1016/0006-8993(90)90889-J
  51. Kowall NW. Beta amyloid neurotoxicity and neuronal degeneration in Alzheimer's disease. Neurobiol Aging 1994;15:257-258. / Neurobiol Aging (1994)
Dates
Type When
Created 13 years, 3 months ago (May 13, 2012, 9:23 a.m.)
Deposited 1 year, 5 months ago (March 27, 2024, 6:16 a.m.)
Indexed 3 months, 2 weeks ago (May 10, 2025, 12:49 a.m.)
Issued 28 years, 11 months ago (Sept. 1, 1996)
Published 28 years, 11 months ago (Sept. 1, 1996)
Published Print 28 years, 11 months ago (Sept. 1, 1996)
Funders 0

None

@article{Vermersch_1996, title={Specific tau variants in the brains of patients with myotonic dystrophy}, volume={47}, ISSN={1526-632X}, url={http://dx.doi.org/10.1212/wnl.47.3.711}, DOI={10.1212/wnl.47.3.711}, number={3}, journal={Neurology}, publisher={Ovid Technologies (Wolters Kluwer Health)}, author={Vermersch, P. and Sergeant, N. and Ruchoux, M. M. and Hofmann-Radvanyi, H. and Wattez, A. and Petit, H. and Dewailly, Ph. and Delacourte, A.}, year={1996}, month=sep, pages={711–717} }